UBAP2L and hepatocellular carcinoma: The expression of UBAP2L was associated with a poor prognosis in cervical cancer [57], having been associated with the activation of the Wnt/β-catenin signalling pathway in gastric cancer [58] and with the regulation of PI3K/AKT and P53 signalling pathways in hepatocellular carcinoma [59].